Michael Hadley: SCOT-HEART 2 Trail Could Transform How We Think About Identifying Those at Risk of Heart Attacks
Michael Hadley, System Director of Advanced Cardiac Imaging at Northwell Health, shared on LinkedIn:
”The SCOT-HEART 2 trail could transform how we think about identifying those at risk of heart attacks.
This ongoing study is randomizing asymptomatic individuals ages 40-70 with 1 or more risk factors for heart disease to either Coronary CTA or standard care, with appropriate therapies, and following for a primary outcome of heart attack.
If the trial is positive, guidelines could recommend broader CT screening of asymptomatic adults, allowing us to detect and treat coronary disease earlier to prevent more heart attacks.
To prepare, we need to model out what a positive trial could mean for patient volumes and what it would take to meet that need.”
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 16:17ASH Is In Search of the Next Team of Authors for the 2026 ASH News Daily
-
Apr 14, 2026, 16:02EU List of Critical Medicines Webinar Recording Now Available – EHC
-
Apr 14, 2026, 15:54Omar Adwan: Patterns of Anemia
-
Apr 14, 2026, 15:43Webinar on Aplastic Anemia Clinical Case – ASH
-
Apr 14, 2026, 15:42Heghine Khachatryan: Endometriosis Is Not Only a Pain Disorder
-
Apr 14, 2026, 15:36Alisha Tuck: Navigating the First Trimester with Ultrasound and Anticoagulation Management
-
Apr 14, 2026, 15:26Tijjani Balas: The End of ‘Type O Negative’ Shortages? – A New Era in Blood Transfusion
-
Apr 14, 2026, 15:07Carlos Henrique Del Carlo: HFpEF Reimagined as an Adipose Tissue Driven Disease
-
Apr 14, 2026, 15:05Matteo Foschi: ASPERA-R Study Reveals Competing Causes Of Breakthrough Stroke On Anticoagulation